Stop-loss on the minds of MARKSANS investors as it ranked worse than it's peers
01 Feb, 20265 min read
MARKSANS PHARMA LIMITED underperformed broader market on Sunday. It grew by +2.57% to close at 168.06. It is currently trading -38% below it's 52 week high of 272.93.